Search

Boehringer Ingelheim Convenes Educational Meetings to Empower Over 300 Regional Experts with Latest Heart Failure Advances

• Boehringer Ingelheim hosted ‘Heart Talks’and ‘MEDEX’ to discuss latest updates in heart failure management and help improve patient outcomes across India, the Middle East and Africa

Boehringer Ingelheim Opens New Scientific Office in Kenya as Part of its Commitment to Improve Human and Animal Health in Africa

Boehringer Ingelheim has officially opened its new scientific office in Nairobi, Kenya.

Boehringer Ingelheim commences local production of first batch of antihypertensive medicines

Boehringer Ingelheim commences local production of first batch of antihypertensive medicines in Algeria

‘Angels’ Initiative is Launched to Deliver Medical Education on Stroke Management at University

‘Angels’ Initiative is Launched to Deliver Medical Education on Stroke Management at University Hospitals

Antibody therapeutics business partnering PetMedix

Combining PetMedix’ expertise in veterinary biotherapeutic technology with Boehringer Ingelheim’s long experience and innovation in human antibody discovery and development provides a unique opportunity for the partners.

World Water Day: Good Health Hinges on Good Water

Clean, safe and accessible water is the most basic prerequisite for life and health

Our Curiosity Never Stops

Dr. Cornelia Dorner-Ciossek shares her thoughts on the future of brain disease research.

Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future

Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats

Boehringer Ingelheim announces Reach Africa Access Healthcare programs outcomes

Boehringer Ingelheim, announces “In Reach Africa” Access to Healthcare programs outcomes

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program

Stroke Prevention in AF

The beginning of the end for KRAS cancers

Learn how Darryl McConnell & his team are tackling the “the beating heart of cancer”

Nurjanahs Story

Nurjanah went from a sporty young woman to someone who no longer had the energy to do simple, everyday tasks. She was diagnosed with scleroderma.

Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom

Boehringer Ingelheim unites dermatologists to discuss the management of Generalized Pustular Psoriasis (GPP)

The ‘GPP Summit, discussed latest research and advances in the management of GPP to help improve patient outcomes across Saudi Arabia, and the United Arab Emirates.

1990-2022: Value through Innovation

The Boehringer Ingelheim history from 1990 to 2022, with milestones

The UAE MOHAP Approves the First and Only Therapy for the Treatment of Adult Generalized Pustular Psoriasis Flares

The first treatment of its kind in the UAE by Boehringer Ingelheim is the only FDA and EMA-approved medication used to treat GPP flares in adult patients and works to help block a source of inflammation that may cause GPP flares

10 things you should know about rabies

Ileitis prevention vaccination Lawsonia intracellularis pig

Cause, impact and prevention: Learn the essentials about Ileitis

Contact us

Find all our contact information here about our BD&L team.

International Women's Day

We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”

Facts about the INPULSIS™ trials

About Us

Human Health

Animal Health

Science & Innovation

Partnering